Five Year Follow Up Results of Surgically Treated Rectal Cancer Case, Who Had Neoadjuvan Chemotheraph

Aim: We wanted to investigate whether the watch and wait method without surgery or surgery is superior in patients with rectal cancer receiving neoadjuvant treatment. Material and Methods: The clinical data of case above the age of 18 who were diagnosed with rectal tumors between 2018 and 2023 were retrospectively analyzed. Results: After neoadjuvant treatment, the mass disappeared completely in some case. All case were operated after neoadjuvant treatment. Adenocarcinoma was seen in 140 (80%) case operated after neoadjuvant treatment, normal colon wall was seen in 10 (5.5%) case and chronic inflammation was seen in 20 (11%) case. Conclusion: The importance of neoadjuvant treatment according to the stage of the disease in case with rectal cancer is being better understood day by day. Early surgery is recommended as the first-line treatment for early-stage rectal cancer due to its favorable outcomes. However, it has been widely accepted that in locally advanced or advanced rectal cancers with lymph node metastasis, neoadjuvant treatment before surgery is much more beneficial in terms of disease-free survival and survey after surgery